Advances in Research of Asthma and Chronic Obstructive Pulmonary Disease

A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Chronic Care".

Deadline for manuscript submissions: 28 February 2025 | Viewed by 652

Special Issue Editors


E-Mail Website
Guest Editor
Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece
Interests: asthma; COPD; sleep apnea; CPAP treatment; lung cancer; pharmacology; infectious diseases
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Department of Speech and Language Therapy, School of Medicine of Patras University, 26504 Rio, Greece
Interests: general practice; preventive medicine

Special Issue Information

Dear Colleagues,

It is my pleasure to invite you to take part in the upcoming Special Issue entitled “Advances in Research of Asthma and Chronic Obstructive Pulmonary Disease” in Healthcare (ISSN 2227-9032).

Asthma and Chronic obstructive pulmonary disease are common respiratory illnesses affecting millions of patients worldwide. In the last decade, many randomized clinical trials have produced enough evidence for the use of novel treatments that are changing patients’ lives. However, there is still a lot to be done to facilitate diagnosis and treatment of both obstructive lung diseases. Investigational drugs are in the pipeline and emerging treatments are expected to help patients alleviate their symptoms.

This issue is open to original research papers, case series, and reviews. The objective of this Special Issue is to illustrate currently available treatments and analyze evolving treatments and other therapeutic modalities for asthma and COPD. We also take an interest in manuscripts that describe advances in diagnostic and monitoring tools. Main topics include, but are not limited to: (1) inhaled treatments; (2) biologics in asthma and COPD; (3) rehabilitation in COPD; (4) monitoring and home care with home spirometry; (5) inflammatory pathways in asthma and COPD.

Along with the journal staff, I will personally be available to assist you in preparing your manuscript for this Special Issue. Worldwide participation and knowledge sharing are highly encouraged. You are more than welcome to contact me directly for any questions. Thank you in advance.

Dr. Dimosthenis Lykouras
Dr. Panagiotis Plotas
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • asthma
  • COPD

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 478 KiB  
Article
Cognitive Functioning Influences Mortality Risk Among Older Adults with COPD
by Srikanta Banerjee, Jagdish Khubchandani, Elizabeth England-Kennedy, Rhonda McIntyre, Karen Kopera-Frye and Kavita Batra
Healthcare 2024, 12(22), 2220; https://doi.org/10.3390/healthcare12222220 - 7 Nov 2024
Viewed by 420
Abstract
Background/Objeectives: Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality in the United States (U.S.), with rates varying by disease severity, comorbidities, and sociodemographic factors. Cognitive impairment has been independently associated with increased mortality, but has not been well studied in [...] Read more.
Background/Objeectives: Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality in the United States (U.S.), with rates varying by disease severity, comorbidities, and sociodemographic factors. Cognitive impairment has been independently associated with increased mortality, but has not been well studied in relation to COPD despite being a frequently overlooked comorbidity in COPD patients. The purpose of this nationwide study was to assess the relationship between low cognitive performance and the risk of mortality among older adults with COPD while adjusting for major sociodemographic and health-related characteristics. Methods: This study utilized the 1999–2002 National Health and Nutrition Examination Survey (NHANES) and the respiratory mortality data of noninstitutionalized US adults aged over 65 years. Survival curves showing the combined effect of cognitive decline and COPD using the Kaplan–Meier product-limit method to estimate the percent survival of the subject at each point in time were used. Results: The final sample included 2013 older adults, with 39.1% showing low cognitive performance and 12.7% having COPD. Those with low cognitive performance were older, less educated, had lower income, were more likely to be racial/ethnic minorities, and had a history of cardiovascular diseases (CVD); they were also more likely to have COPD or chronic kidney disease (CKD). The adjusted hazard ratio for respiratory-related mortality risk was highest for individuals with both COPD and low cognitive performance (hazards ratio = 8.53), people with COPD alone also had a higher respiratory-related mortality risk (hazards ratio = 4.92), but low cognitive performance alone did not significantly increase respiratory-related mortality risk. Conclusions: These findings provide clearer insights into how cognitive impairment affects mortality risk in older adults with COPD and we discuss potential strategies to address this dual chronic health challenge effectively. Full article
Show Figures

Figure 1

Back to TopTop